Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP319865.RAVu3eK0TDIRnelQx6XUgCOew_tTyFACz54D7xkuhQz4A130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP319865.RAVu3eK0TDIRnelQx6XUgCOew_tTyFACz54D7xkuhQz4A130_assertion type Assertion NP319865.RAVu3eK0TDIRnelQx6XUgCOew_tTyFACz54D7xkuhQz4A130_head.
- NP319865.RAVu3eK0TDIRnelQx6XUgCOew_tTyFACz54D7xkuhQz4A130_assertion description "[Multivariate analysis revealed an inferior overall survival and a higher AML transformation rate for the genotype ZRSR2(mut)/TET2(wt) (overall survival: hazard ratio = 3.3; 95% CI, 1.4-7.7; P = .006; AML transformation: hazard ratio = 3.6; 95% CI, 2-4.2; P = .026).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP319865.RAVu3eK0TDIRnelQx6XUgCOew_tTyFACz54D7xkuhQz4A130_provenance.
- NP319865.RAVu3eK0TDIRnelQx6XUgCOew_tTyFACz54D7xkuhQz4A130_assertion evidence source_evidence_literature NP319865.RAVu3eK0TDIRnelQx6XUgCOew_tTyFACz54D7xkuhQz4A130_provenance.
- NP319865.RAVu3eK0TDIRnelQx6XUgCOew_tTyFACz54D7xkuhQz4A130_assertion SIO_000772 22343920 NP319865.RAVu3eK0TDIRnelQx6XUgCOew_tTyFACz54D7xkuhQz4A130_provenance.
- NP319865.RAVu3eK0TDIRnelQx6XUgCOew_tTyFACz54D7xkuhQz4A130_assertion wasDerivedFrom befree-20140225 NP319865.RAVu3eK0TDIRnelQx6XUgCOew_tTyFACz54D7xkuhQz4A130_provenance.
- NP319865.RAVu3eK0TDIRnelQx6XUgCOew_tTyFACz54D7xkuhQz4A130_assertion wasGeneratedBy ECO_0000203 NP319865.RAVu3eK0TDIRnelQx6XUgCOew_tTyFACz54D7xkuhQz4A130_provenance.